Dr Kislay Roy




Filter by


Recent advances in nanomedicine and survivin targeting in brain cancers

J Mazur, K Roy, J Kanwar

(2018), Vol. 13, pp. 105-137, Nanomedicine (London, England), London, Eng., C1


Topical ophthalmic formulation of Trichostatin A and SurR9-C84A for quick recovery post-alkali burn of corneal haze

K Roy, C Cheung, R Kanwar, R Sandhir, J Kanwar

(2017), Vol. 8, pp. 1-15, Experimental pharmacology and drug discovery, Lausanne, Switzerland, C1


Characterization and molecular mechanism of peptide-conjugated gold nanoparticle inhibiting p53-HDM2 interaction in retinoblastoma

S Kalmodia, S Parameswaran, K Ganapathy, W Yang, C Barrow, J Kanwar, K Roy, M Vasudevan, K Kulkarni, S Elchuri, S Krishnakumar

(2017), Vol. 9, pp. 349-364, Molecular therapy - nucleic acids, Amsterdam, The Netherlands, C1


Biodegradable Eri silk nanoparticles as a delivery vehicle for bovine lactoferrin against MDA-MB-231 and MCF-7 breast cancer cells

K Roy, Y Patel, R Kanwar, R Rajkhowa, X Wang, J Kanwar

(2016), Vol. 11, pp. 25-44, International journal of nanomedicine, Macclesfield, Eng., C1


Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents

R Chaudhary, K Roy, R Kanwar, K Walder, J Kanwar

(2016), Vol. 14, pp. 1-17, Journal of nanobiotechnology, London, Eng., C1


Comparative activities of milk components in reversing chronic colitis

J Kanwar, R Kanwar, S Stathopoulos, N Haggarty, A MacGibbon, K Palmano, K Roy, A Rowan, G Krissansen

(2016), Vol. 99, pp. 2488-2501, Journal of dairy science, Atlanta, Ga., C1


Survivin modulators: an updated patent review (2011-2015)

K Roy, N Singh, R Kanwar, J Kanwar

(2016), Vol. 11, pp. 152-169, Recent patents on anti-cancer drug discovery, Beijing, China, C1


Theranostic multimodular potential of zinc-doped ferrite-saturated metal-binding protein-loaded novel nanocapsules in cancers

S Kamalapuram, R Kanwar, K Roy, R Chaudhary, R Sehgal, J Kanwar

(2016), Vol. 11, pp. 1349-1366, International journal of nanomedicine, Macclesfield, Eng., C1


Ophthalmic combination of SurR9-C84A and trichostatin-A targeting molecular pathogenesis of alkali burn

K Roy, B Sriramoju, R Kanwar, J Kanwar

(2016), Vol. 7, pp. 1-14, Frontiers in Pharmacology, Lausanne, Switzerland, C1


E-cadherin aptamer-conjugated delivery of doxorubicin for targeted inhibition of prostate cancer cells

R Chaudhary, K Roy, R Kanwar, R Veedu, S Krishnakumar, C Cheung, A Verma, J Kanwar

(2016), Vol. 69, pp. 1108-1116, Australian journal of chemistry, Clayton, Vic., C1


Fe-bLf nanoformulation targets survivin to kill colon cancer stem cells and maintains absorption of iron, calcium and zinc

J Kanwar, V Mahidhara, K Roy, S Sasidharan, S Krishnakumar, N Prasad, R Sehgal, R Kanwar

(2015), Vol. 10, pp. 35-55, Nanomedicine, London, United Kingdom, C1


Competitive inhibition of survivin using a cell-permeable recombinant protein induces cancer-specific apoptosis in colon cancer model

K Roy, R Kanwar, S Krishnakumar, C Cheung, J Kanwar

(2015), Vol. 10, pp. 1019-1043, International journal of nanomedicine, Auckland, N. Z., C1


Nucleic acid-based aptamers: applications, development and clinical trials

J Kanwar, K Roy, N Maremanda, K Subramanian, R Veedu, R Bawa, R Kanwar

(2015), Vol. 22, pp. 2539-2557, Current medicinal chemistry, Bussum, The Netherlands, C1


Evaluation of nanoformulated therapeutics in an ex-vivo bovine corneal irritation model

B Sriramoju, K Roy, R Kanwar, J Kanwar

(2015), Vol. 29, pp. 917-925, Toxicology in vitro, Amsterdam, The Netherlands, C1


Locked nucleic acid modified bi-specific aptamer-targeted nanoparticles carrying survivin antagonist towards effective colon cancer therapy

K Roy, R Kanwar, C Antonio Cheung, C Lee Fleming, R Veedu, S Krishnakumar, J Kanwar

(2015), Vol. 5, pp. 29008-29016, RSC advances, Cambridge, Eng., C1


Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions

J Kanwar, K Roy, Y Patel, S-F Zhou, M Singh, D Singh, M Nasir, R Sehgal, A Sehgal, R Singh, S Garg, R Kanwar

(2015), Vol. 20, pp. 9703-9731, Molecules, Basel, Switzerland, C1-1


Targeting VEGF with LNA-stabilized G-rich oligonucleotide for efficient breast cancer inhibition

S Edwards, V Poongavanam, J Kanwar, K Roy, K Hillman, N Prasad, R Leth-Larsen, M Petersen, M Maru?i?, J Plavec, J Wengel, R Veedu

(2015), Vol. 51, pp. 9499-9502, Chemical Communications, London, Eng., C1


Oral administration of iron-saturated bovine lactoferrin-loaded ceramic nanocapsules for breast cancer therapy and influence on iron and calcium metabolism

G Mahidhara, R Kanwar, K Roy, J Kanwar

(2015), Vol. 10, pp. 4081-4098, International journal of nanomedicine, Auckland, N. Z., C1


LNA aptamer based multi-modal, Fe3O4-saturated lactoferrin (Fe3O4-bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imaging

K Roy, R Kanwar, J Kanwar

(2015), Vol. 71, pp. 84-99, Biomaterials, Amsterdam, The Netherlands, C1


Molecular targets in arthritis and recent trends in nanotherapy

K Roy, R Kanwar, J Kanwar

(2015), Vol. 10, pp. 5407-5420, International journal of nanomedicine, Auckland, N. Z., C1


Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells

N Maremanda, K Roy, R Kanwar, V Shyamsundar, V Ramshankar, A Krishnamurthy, S Krishnakumar, J Kanwar

(2015), Vol. 9, pp. 1-20, Biomicrofluidics, Maryland, United States, C1


Bioceramic nanomaterials in medical applications

J Kanwar, G Mahidhara, K Roy, R Kanwar

(2014), pp. 163-175, Bioengineered nanomaterials, Boca Raton, Flo., B1


Chimeric aptamers in cancer cell-targeted drug delivery

J Kanwar, K Roy, R Kanwar

(2011), Vol. 46, pp. 459-477, Critical reviews in biochemistry and molecular biology, London, England, C1


Applications of aptamers in nanodelivery systems in cancer, eye and inflammatory diseases

J Kanwar, R Mohan, R Kanwar, K Roy, R Bawa

(2010), Vol. 5, pp. 1435-1445, Nanomedicine, London, England, C1


Funded Projects at Deakin

No Funded Projects at Deakin found


Associate Supervisor

Mohamed Ayman Abdelhamid Abdel Aboda

Thesis entitled: Multimodal Therapy and Molecular Exosomal-microRNA Biomarkers for Cancer Cachexia

Doctor of Philosophy (Medicine), School of Medicine